NETs and CF Lung Disease: Current Status and Future Prospects.

Area of Science:

• Immunology
• Pulmonology
• Genetics

Background:

• Cystic Fibrosis (CF) is a fatal monogenic disease causing progressive lung destruction via chronic infection and inflammation.
• CF airways exhibit an innate immune defect, leading to early colonization by bacteria like Staphylococcus aureus and Pseudomonas aeruginosa.
• Neutrophils are key effector cells in CF airways, crucial for bacterial killing but also implicated in lung damage.

Purpose of the Study:

• To critically discuss the dual role of Neutrophil Extracellular Traps (NETs) in Cystic Fibrosis (CF) lung pathogenesis.
• To explore the potential antimicrobial functions and tissue-damaging properties of NETs in the CF airway microenvironment.
• To evaluate the therapeutic implications of targeting NETs, particularly through DNase therapy, in CF management.

Main Methods:

• Review and critical discussion of existing literature on NETs in CF.
• Analysis of neutrophil burden and products, including neutrophil elastase and extracellular nuclear material, in CF airways.
• Consideration of CF animal models, such as the CFTR(-/-) pig, for studying NETs' role.

Main Results:

• Neutrophil extracellular traps (NETs) are implicated in both bacterial defense and lung injury in CF.
• NETs release proteases and other factors contributing to CF-related lung damage and inflammation.
• Inhaled DNase therapy, targeting nuclear material, improves lung function and reduces exacerbations in CF, potentially via NET degradation.

Conclusions:

• NETs represent a significant factor in CF lung pathology, contributing to both host defense and tissue destruction.
• Targeting NETs, possibly through DNase therapy, offers a promising therapeutic strategy for Cystic Fibrosis.
• Further research using relevant CF animal models is essential to fully elucidate the role of NETs in CF pathogenesis.